UNSPSC 51283714: Cefamandole nafate

This classification denotes a cephalosporin antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8HDO7941DO. European Medicines Agency schedules Cefamandole nafate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01101MIG. Cefamandole nafate generally arises in the molecular formula C19H17N6NAO6S2. The term 'cefamandole nafate' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule cefamandole nafate under HS 29419000 and SITC 54139.

As of Q4 2014, CEFAMANDOLE NAFATE remains US FDA's Preferred Term for this commodity. Cefamandole nafate bears US NLM identifiers UMLS ID C0054995 and NCI Concept Code C47966. SMILES: CN1C(NNN1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)[C@@H](C4CCCCC4)OC=O)SC2)C(=O)[O-].[NA+].

UNSPSC 51283714 Cefamandole nafate is a Commodity code nominally identifying a specific antibiotic pharmaceutical, but the recent state and local opportunities tagged to this code show little procurement activity directly aligned with that product. Instead, the code appears in solicitations for broader pharmaceutical and medical supply categories: naloxone and drug deactivation systems, generic multi-source pharmaceuticals and OTC products, medical and first aid supplies for emergency response, and exploratory direct-to-manufacturer prescription programs. The actual buying under this code spans emergency medical supplies, pharmacy benefit management, and clinical consumables purchased by county health departments, state health commissions, fire departments, and cooperative purchasing consortiums. Issuing bodies include county health authorities (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), municipal fire and rescue departments (Tampa Fire Department), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving multiple jurisdictions including Oregon).

Recent opportunities reflect activity across Florida, Texas, Minnesota, and Oregon. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries, due July 26, 2023. The City of Tampa's Purchasing Department posted IFB 26-P-00145 on March 25, 2026, for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000.00 and a response deadline of March 13, 2026; this procurement is sheltered for certified Small Local Business Enterprises with a 5 percent bid discount. The Minnesota Department of Administration issued RFP S1070000015802 through MMCAP on January 20, 2026, establishing multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local facilities, with responses due March 26, 2026 and contract effectiveness July 1, 2026. The Texas HHS Commission posted RFI HHS0017013 on April 3, 2026, as a preliminary market-intelligence solicitation exploring direct-to-manufacturer prescription programs without formal award timelines or budget commitment. The code shows fragmented buying patterns across health systems, emergency services, and state purchasing cooperatives rather than concentrated procurement of the specific pharmaceutical named in the code.